Liminal BioSciences Inc. (LMNL) News Headlines

▮ More

Date

Headline

11/18/2020 5:56:37 AM Pre-market Movers In Healthcare Sector: KZIA, LMNL, OCGN, INO, ONCT...

11/12/2020 5:45:00 AM Pre-market Movers In Healthcare Sector: IMAC, BNGO, LMNL, FPRX, EQ…

11/8/2020 7:32:36 PM Liminal BioSciences FDA Extends Review Period For Ryplazim BLA To June 5, 2021 From March 5, 2021

10/30/2020 8:34:27 AM Liminal BioSciences Announces Private Placement Financing Of $30 Mln

9/21/2020 8:22:06 AM Liminal BioScience : FDA Assigns PDUFA Target Action Date Of March 5

9/8/2020 6:05:26 AM Liminal BioSciences Announces Resubmission Of BLA For Ryplazim For Treatment Of Congenital Plasminogen Deficiency

9/8/2020 6:00:00 AM Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for Ryplazim® (plasminogen) for Treatment of Congenital Plasminogen Deficiency (Press Release)

8/24/2020 5:47:03 PM After Market Hours: VivoPower, Arcturus Therapeutics, Tortoise Gain; Liminal, Portland General Slip

8/24/2020 9:52:20 AM Stock Alert: Liminal BioSciences Jumps 45%

8/24/2020 6:50:50 AM Pre-market Movers In Healthcare Sector: SONN, ADMA, THMO, LMNL, KMDA...

8/4/2020 3:31:42 AM ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

7/31/2020 2:50:46 AM PRPO Up 400% As It Readies For Rollout Of COVID-19 Test, LXRX Realigns Business, VRTX Boosts Outlook

7/17/2020 8:00:00 AM Liminal BioSciences Broadens R&D Pipeline With Novel Preclinical Program For Eosinophilic-Driven Diseases (Press Release)

7/7/2020 3:45:41 AM BLU Plunges On RELIEF Data, FDA Places CLLS' Trial On Hold, IMMU Hits New High, OTIC Music To Ears

7/2/2020 1:08:19 AM LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch

1/13/2020 7:00:00 AM Liminal BioSciences Outlines Corporate Priorities for 2020 (Press Release)

6/14/2019 3:34:30 AM Prometic Announces Four Abstracts Highlighting Progress In Developing PBI-4050

12/19/2018 7:32:29 AM Prometic Life Sciences Names Simon Best As Interim CEO; Pierre Laurin Has Stepped Down

8/7/2018 7:13:14 AM Prometic Receives Rare Pediatric Disease Designation From FDA For Small Molecule Drug Candidate, PBI-4050

4/30/2018 6:33:39 AM Prometic Reports Positive Clinical Data From IVIG Pivotal Phase 3 Trial; Meets Primary And Secondary Endpoints

Liminal Biosciences Inc. (LMNL)